CytomX Therapeutics, Inc. CTMX 36.17
Health Care · NASDAQ · Data as of 2026-08-06
CytomX Therapeutics, Inc. (CTMX) has delivered +15.2% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1633 of 1968 stocks overall and #202 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
36.17
Overall Rank
#1633 / 1968
Sector Rank
#202 / 260
Revenue CAGR
+15.2%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio